---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-037367"
form_type: "8-K"
ticker: "ETON"
cik: "0001710340"
company_name: "Eton Pharmaceuticals, Inc."
filed_at: "2024-12-12T23:59:59+00:00"
generated_at: "2026-05-29T04:09:33.771272+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Eton Pharmaceuticals raises $7.0M in registered direct offering of 583,334 shares at $12.00/share

## Summary
- Entered Securities Purchase Agreement on Dec 10, 2024 with an institutional investor.
- Gross proceeds approximately $7.0 million from sale of 583,334 shares at $12.00 per share.
- No placement agent; shares offered under effective S-3 registration statement.
- Proceeds intended for funding acquisition opportunities for products or product candidates.
- Shares will be issued free of restrictive legends.

## SEC filing metadata
- accession: 0001437749-24-037367
- form_type: 8-K
- ticker: ETON
- cik: 0001710340
- company_name: Eton Pharmaceuticals, Inc.
- filed_at: 2024-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1710340/000143774924037367/0001437749-24-037367-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1710340/000143774924037367/eton20241211_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-037367
- JSON: https://secwatch.observer/filing/0001437749-24-037367.json
- Plain text: https://secwatch.observer/filing/0001437749-24-037367.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.